Ex-FrontPoint Trader Ends $30M SEC Insider Trading Suit
The U.S. Securities and Exchange Commission said Wednesday that it had settled its $30 million pharmaceutical stock insider trading suit in New York against ex-FrontPoint Partners LLC trader Joseph Skowron, though...To view the full article, register now.
Already a subscriber? Click here to view full article